余仁生EuYanSang品牌怎么样 申请店铺

我要投票 余仁生EuYanSang在燕窝行业中的票数:597 更新时间:2026-01-03
余仁生EuYanSang是哪个国家的品牌?「余仁生EuYanSang」是余仁生商贸(广东)有限公司旗下著名品牌。该品牌发源于广东,由创始人毛益斌在2006期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力余仁生EuYanSang品牌出海!将品牌入驻外推网,定制余仁生EuYanSang品牌推广信息,可以显著提高余仁生EuYanSang产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

余仁生EuYanSang怎么样

致力领先中药业

逾130年前,我们在马来西亚霹雳州的务边小镇,开了首家为采矿劳工服务的小中药铺。耕耘至今,余仁生在亚洲已经成为家喻户晓的优质中医药保健品牌。

我们从原料挑选、生产制造、以及成品销售,到看诊治疗的每个流程,都全力保持品质优良标准。这份用心使我们在中药界中保持绝佳的竞争优势。

为了巩固余仁生于业界的领导地位,我们不断观察市场消费趋势和需求的转变,在新产品研发和销售网络扩建的策略上不断的改革、创新。

坚持提供优质产品

品质为先,力求完美,是余仁生创业以来的宗旨,也是余仁生对顾客一直信守的承诺。

我们销售品质优良的中药材、中成药、健康食品和营养补充品;以“余仁生”及其他延伸品牌推出逾900种产品和上千种中药材及其他中药产品。

我们执意提供优质的产品。为此,集团旗下制药生产设施的运作,完全符合国际规范。余仁生在香港及马来西亚的制药厂均获得"优良药品生产作业规范"(GMP)认证。香港元朗制药厂的设施更取得澳洲药品管理局"优良药品管理"(TherapeuticGoodsAdministration,TGA)认证。

我们率先推出世界首个中草药品鉴标准—"余仁生优良中药农业科学规范"(EuYanSangGoodAgronomicPracticesforHerbs,简称EYSGAP–Herbs),以确保中药产品从种植、生产到销售的所有过程都经过严谨监控,保证产品质量安全。

配合全新标准,余仁生也投入发展iGATES(IntegratedGoodAgronomicPracticeforTraditionalChineseMedicineElectronicSystem)资讯入门网,整合中药指纹图谱及各项国际品质安全规范的所有资讯,来加强中草药的可追溯性,进一步提高药品安全性。

完善扩展业务网络

余仁生广泛的销售网络遍布亚洲各地,在香港、马来西亚、新加坡、澳门和中国大陆拥有逾200家零售商店。我们的产品也可在各地上千家连锁式药房、中药店、超级市场、便利商店、医院、保健中心及温泉疗养中心购得。

此外,我们也提供全面的保健服务,融汇中、西医药保健服务的精粹,在新加坡和马来西亚经营24家中医诊所,并在香港设立两家综合医疗中心。

余仁生在2012年2月扩大其事业版图至澳大利亚,收购了约100家HealthyLife连锁店及批发中心。

发展愿景

展望未来,我们将积极巩固余仁生在中药界、综合保健及养生领域的领先地位,而我们"仁泽众生"的经营理念,也始终不变。

More than 130 years ago, we opened the first small TCM shop for mining workers in Wubian Town, Perak, Malaysia. Till now, Yu Rensheng has become a well-known brand of high-quality Chinese medicine and health care in Asia. We try our best to maintain high quality standards in every process from raw material selection, manufacturing, and finished product sales to clinical treatment. This intention enables us to maintain an excellent competitive advantage in the field of traditional Chinese medicine. In order to consolidate Yu Rensheng's leading position in the industry, we constantly observe the change of market consumption trend and demand, and constantly reform and innovate in the strategy of new product R & D and sales network expansion. The tenet of Yu Rensheng since he started his business is to provide high-quality products first and strive for perfection, which is also the promise Yu Rensheng has always kept to customers. We sell high-quality traditional Chinese medicine, proprietary Chinese medicine, healthy food and nutritional supplements, and launch more than 900 products and thousands of traditional Chinese medicine and other traditional Chinese medicine products with "Yu Rensheng" and other extended brands. We are determined to provide high-quality products. For this reason, the operation of pharmaceutical production facilities under the group fully complies with international norms. Yu Rensheng's pharmaceutical plants in Hong Kong and Malaysia have obtained GMP certification. The facilities of the Hong Kong Yuen Long pharmaceutical factory have also been certified by the Australian drug administration as "therapeutic good administration" (TGA). We take the lead in launching the world's first Chinese herbal medicine evaluation standard - "Eu Yan Sang good agricultural practices for herbas" (eygap - herbas for short), to ensure that all the processes of Chinese herbal medicine products from planting, production to sales are strictly monitored to ensure product quality and safety. In line with the new standards, Yu Rensheng has also invested in the development of the integrated good agricultural practice for traditional Chinese medical electronic system (igates) information portal, integrating the fingerprint of traditional Chinese medicine and all the information of various international quality and safety standards, so as to enhance the traceability of traditional Chinese medicine and further improve the drug safety. Improve and expand business network Yu Rensheng's extensive sales network throughout Asia, with more than 200 retail stores in Hong Kong, Malaysia, Singapore, Macao and Mainland China. Our products can also be purchased in thousands of chain pharmacies, traditional Chinese medicine stores, supermarkets, convenience stores, hospitals, health centers and spa centers. In addition, we also provide comprehensive health care services, integrate the essence of Chinese and Western medicine health care services, operate 24 TCM clinics in Singapore and Malaysia, and set up two comprehensive medical centers in Hong Kong. Yu Rensheng expanded his business to Australia in February 2012 and acquired about 100 healthylife chain stores and wholesale centers. Looking forward to the future, we will actively consolidate Yu Rensheng's leading position in the field of traditional Chinese medicine, comprehensive health care and health preservation, and our business philosophy of "Renze all living creatures" will remain unchanged.

本文链接: https://brand.waitui.com/5c5784b8d.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

创历史新高!2025年中国航天发射次数达92次

记者从国家航天局获悉,2025年,我国在载人航天、深空探测、商业航天等领域完成多项突破,实现多个首次。2025年,中国航天全年发射次数达到92次,创历史新高。 (央视新闻)

3分钟前

元旦假期,敦煌莫高窟客流同比上涨约30%

敦煌研究院文化弘扬部部长雷政广:从预约数据来看,今年莫高窟元旦假期的游客,增幅应该在30%左右。冬春旅游季,莫高窟的游客主要是以年轻人为主,另外散客占了90%以上的比例。同时省外游客和入境游客,增幅也比较突出。(新浪财经)

3分钟前

元旦后陆续入市的公募资金规模在430亿元以上

2026年市场徐徐展开,截至2025年12月31日,元旦后陆续入市的公募资金规模在430亿元以上。一是拟于元旦后上市的16只ETF,合计资金规模近50亿元;二是于2025年11月后成立的60多只处于建仓初期的主动权益基金,合计规模约为380多亿元。 券商中国记者采访了解到,新年上市ETF的持有人,以个人投资者居多,不少产品的个人投资者持有份额占比在90%以上。从底层资金来源看,根据机构预测,居民储蓄资金入市潜力巨大。2026年非定存投资领域有望额外新增2万亿元—4万亿元左右的活化资金。 受访人士对券商中国记者表示,2026年股票投资有望继续领跑,期待居民储蓄能更显著进入股票市场。2026年科技投资难度将大于2025年,超额收益将更依赖于对产业节奏的精准把握和个股的深度甄别,挑战增加,但结构性机遇依然丰富。(e公司)

3分钟前

Netflix收购华纳后拟将上映期缩至17天

1月2日,有消息称流媒体巨头Netflix希望在完成对华纳兄弟的收购后,将华纳兄弟电影的院线独占放映期缩短至17天,这一做法引发传统影院及好莱坞电影创作者的担忧。媒体称,在讨论《怪奇物语》第五季大结局院线放映表现时,好莱坞业内对Netflix所称的“行业标准放映窗口”表达了疑虑。消息人士称,Netflix一直主张17天的院线窗口期,而包括AMC在内的院线方则坚持认为应维持在目前常见的45天左右。尽管Netflix尚未最终确定此政策,且未来可能与影院院线协商出一个介于17至45天之间的折中方案,但业内普遍预期,围绕窗口期的谈判将充满张力,而Netflix的核心重点无疑是巩固其流媒体业务。(格隆汇)

4分钟前

25年飞天茅台散瓶批价跌至1495元/瓶

“今日酒价”披露的最新批发参考价显示,1月3日,25年飞天茅台原箱报1505元/瓶,较上一日降20元;25年飞天茅台散瓶报1495元/瓶,较上一日降15元。(格隆汇)

4分钟前

本页详细列出关于余仁生EuYanSang的品牌信息,含品牌所属公司介绍,余仁生EuYanSang所处行业的品牌地位及优势。
咨询